Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative Diseases.

Liu, Jun; Mouradian, M Maral

Liu, Jun; Mouradian, M Maral.

Affiliation

Liu J; RWJMS Institute for Neurological Therapeutics and Department of Neurology, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
Mouradian MM; RWJMS Institute for Neurological Therapeutics and Department of Neurology, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.

Int J Mol Sci ; 25(4)2024 Feb 17.

Article in En | MEDLINE | ID: mdl-38397040

Subject(s)

Neurodegenerative Diseases; Parkinson Disease; Humans; Neurodegenerative Diseases/metabolism; Protein Glutamine gamma Glutamyltransferase 2; Amyloid beta-Peptides; alpha-Synuclein/metabolism; Parkinson Disease/metabolism; Transglutaminases/metabolism; tau Proteins

Key words

Alzheimer's disease; Huntington's disease; Parkinson's disease; neurodegenerative disorders; protein crosslinking; transglutaminase 2

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Neurodegenerative Diseases Limits: Humans Language: En Journal: Int J Mol Sci Year: 2024 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google